Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS

Apellis Pharmaceuticals (APLS) Technical Analysis

418 Followers

Summary of all the Indicators

Summary
Buy
12Bullish
5Neutral
5Bearish
Oscillators
Neutral
3Bullish
5Neutral
2Bearish
Moving Averages
Buy
9Bullish
0Neutral
3Bearish
Apellis Pharmaceuticals Inc’s (APLS) Moving Averages Convergence Divergence (MACD) indicator is 1.57, suggesting Apellis Pharmaceuticals Inc is a Buy.
Apellis Pharmaceuticals Inc’s (APLS) 20-Day exponential moving average is 86.46, while Apellis Pharmaceuticals Inc’s (APLS) share price is $86.97, making it a Buy.
Apellis Pharmaceuticals Inc’s (APLS) 50-Day exponential moving average is 80.61, while Apellis Pharmaceuticals Inc’s (APLS) share price is $86.97, making it a Buy.

Apellis Pharmaceuticals (APLS) Pivot Points

May 28, 2023, 02:09 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
81.98
83.22
84.18
85.42
86.39
87.63
88.59
Fibonacci
83.22
84.06
84.58
85.42
86.26
86.78
87.63

Apellis Pharmaceuticals (APLS) Moving Averages

May 28, 2023, 02:09 AM
Period
Simple
Exponential
MA5
86.45Buy
86.65Buy
MA10
87.37Sell
87.06Sell
MA20
87.55Sell
86.46Buy
MA50
80.13Buy
80.61Buy
MA100
68.29Buy
72.68Buy
MA200
62.57Buy
65.21Buy
Apellis Pharmaceuticals Inc’s (APLS) 10-Day exponential moving average is 87.06, while Apellis Pharmaceuticals Inc’s (APLS) share price is $86.97, making it a Sell.
Apellis Pharmaceuticals Inc’s (APLS) 100-Day exponential moving average is 72.68, while Apellis Pharmaceuticals Inc’s (APLS) share price is $86.97, making it a Buy.
Apellis Pharmaceuticals Inc’s (APLS) stock price is $86.97 and Apellis Pharmaceuticals Inc’s (APLS) 50-day simple moving average is 80.13, creating a Buy signal.
Apellis Pharmaceuticals Inc’s (APLS) stock price is $86.97 and Apellis Pharmaceuticals Inc’s (APLS) 100-day simple moving average is 68.29, creating a Buy signal.
Apellis Pharmaceuticals Inc’s (APLS) stock price is $86.97 and Apellis Pharmaceuticals Inc’s (APLS) 200-day simple moving average is 62.57, creating a Buy signal.

Apellis Pharmaceuticals (APLS) Technical Indicators

May 28, 2023, 02:09 AM
Name
Value
Action
RSI (14)
54.21
Neutral
STOCH (9,6)
46.66
Neutral
STOCHRSI (14)
37.13
Neutral
MACD (12,26)
1.57
Buy
ADX (14)
19.55
Buy
Williams %R
-53.71
Buy
CCI (14)
-33.08
Neutral
ATR (14)
3.33
-
Ultimate Oscillator
52.63
Neutral
ROC
-4.83
Sell
Apellis Pharmaceuticals Inc’s (APLS) Relative Strength Index (RSI) is 54.21, creating a Neutral signal.
Apellis Pharmaceuticals Inc’s (APLS) Trend Strength Indicator (ADX) is 19.55, creating a Buy signal.
Apellis Pharmaceuticals Inc’s (APLS) Commodity Channel Index (CCI) is -33.08, creating a Neutral signal.
Apellis Pharmaceuticals Inc’s (APLS) Price Rate of Change (ROC) is -4.83, creating a Sell signal.

FAQ

Is APLS a Buy, Hold, or Sell?
Based on APLS’s technical indicators, APLS is a Buy.
    What is APLS’s RSI (14)?
    APLS’s RSI (14) is 54.21, which suggests APLS is a Neutral.
      What is APLS’s MACD?
      APLS’s MACD is 1.57, which suggests APLS is a Buy.
        What is APLS’s 5-day moving average?
        APLS’s 5-day moving average is 86.45, which suggests APLS is a Buy.
          What is APLS’s 20-day moving average?
          APLS 20-day moving average is 87.55, which suggests APLS is a Sell.
            What is APLS’s 50-day moving average?
            APLS’s 50-day moving average is 80.13, which suggests APLS is a Buy.
              What is APLS’s 200-day moving average?
              APLS’s 200-day moving average is 62.57, which suggests APLS is a Buy.
                What is APLS’s Williams % R (14)?
                APLS’s Williams % R (14) is -53.71, which suggests APLS is a Buy.
                  What is APLS’s CCI (14)?
                  APLS’s CCI (14) is -33.08, which suggests APLS is a Neutral.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis